在接受血液透析的男性中,内射分析运动对勃起功能障碍的影响. 一个试点随机控制试验
Rehan G Abdelaziz1, Mohammad Etoom2, Mohamed M Mazen3,4
1Physical Therapy for Burn and Surgery Department, Faculty of Physical Therapy, Delta University for Science and Technology, Gamasa, Egypt.
概括
隔日有氧运动显著改善了经过血液透析的男性的勃起功能障碍 (ED) 和相关的心理结果. 这种安全的干预措施为HD患者的性健康管理提供了有希望的补充.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 运动生理学 运动生理学
背景情况:
- 勃起功能障碍 (ED) 是常见的慢性病 (CKD) 患者接受血液透析 (HD).
- 目前在这个人群中对ED的管理策略有限.
研究的目的:
- 在患有HD的男性中研究静脉内有氧运动对ED的疗效.
- 评估这些练习对心理健康的影响.
主要方法:
- 一个试点随机对照试验 (RCT) 将参与者分配到一个练习或对照组.
- 运动组在12周内每周三次进行了日内分析循环.
- 国际勃起功能指数 (IIEF-5) 是主要结果;次要结果包括自尊,孤独,抑郁和压力.
主要成果:
- 在运动组中观察到IIEF-5得分的显著改善 (p < 0.01,Cohen d = 1.1).
- 二次结果,包括自尊,孤独,抑郁和压力,也显示出显著的改善 (p < 0.001).
- 基线血红蛋白水平是IIEF-5变化的显著共变量;没有报告任何不良事件.
结论:
- 在患有HD的男性中,日内有氧运动是有效和安全的,可以改善ED和相关的心理结果.
- 将这些练习纳入HD管理可能会提高性健康干预措施的有效性.
- 需要进一步研究,以客观的结果和长期的后续行动.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
557
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
557
Disorders of the Male Reproductive System
4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
253
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
253
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932


